HCA Healthcare, Inc. $HCA Shares Sold by Richard Bernstein Advisors LLC

Richard Bernstein Advisors LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 62.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,291 shares of the company’s stock after selling 7,048 shares during the period. Richard Bernstein Advisors LLC’s holdings in HCA Healthcare were worth $1,829,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Clearstead Trust LLC increased its stake in shares of HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in shares of HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $40,000. Compound Global Advisors LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $44,000. Finally, True Wealth Design LLC raised its position in HCA Healthcare by 179.5% in the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after purchasing an additional 70 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock valued at $7,797,595 in the last three months. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $545.88 on Tuesday. The firm has a market cap of $122.07 billion, a P/E ratio of 19.23, a PEG ratio of 1.64 and a beta of 1.34. The stock’s 50 day moving average price is $501.78 and its 200 day moving average price is $466.79. HCA Healthcare, Inc. has a 1 year low of $310.18 and a 1 year high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. HCA Healthcare’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. KeyCorp set a $503.00 target price on shares of HCA Healthcare in a report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Argus raised their price objective on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Finally, Barclays upped their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $534.50.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.